Press Release / U.S. Speech Therapy Market
U.S. Speech Therapy Market to Exhibit a CAGR of 6.9% from 2024 to 2032; Surging Occurrence of Language and Speech Disorders to Boost the Market Development
October 08, 2024 | HealthcareThe U.S. therapy market size stood at USD 4.62 billion in 2023. The market value is slated to rise from USD 4.91 billion in 2024 to USD 8.37 billion by 2032 at a CAGR of 6.9% during 2024-2032. Fortune Business Insights™ presents this information in its report titled “U.S. Speech Therapy Market Size, Share & Industry Analysis, By Type (Speech Disorders, Language Disorders, Neurological Conditions, Swallowing Disorders, and Others), By Age (Pediatrics and Adults), and Country Forecast, 2024-2032”
Speech therapy is inclusive of intervention services, emphasizing enhancing a patient’s abilities and speech to express and understand language, which includes non-verbal language. The growing transition toward teletherapy, coupled with availability of supportive reimbursement policies in the U.S., are poised to provide profitable opportunities of growth to companies, driving market expansion.
The market observed a minimal impact of the COVID-19 pandemic, which can be credited to lockdown restrictions. In addition, the market size was influenced owing to decrease in rate of adoption of these services among the population due to restricted infrastructure for virtual speech-language pathology.
The National Institutes of Health (NIH) Unveiled Tackling Acquisition of Language in Kids (TALK) Initiative to Assist Late-talking Children
In September 2023, the National Institutes of Health (NIH) announced the launch of the Tackling Acquisition of Language in Kids (TALK) Initiative to offer support to children who talk late. This initiative aims to impart information required to support late talking children to caregivers, educators, healthcare professionals, and parents.
Market Growth Can be Attributed to Surging Occurrence of Language and Speech Disorders
The growing number of people in the U.S. diagnosed with language and speech disorders, such as stuttering, aphasia, articulation, and others, creates a high demand for effective treatment therapy. The National Aphasia Association reported over 2 million U.S. adults were diagnosed with aphasia in 2021. The American Speech-Language-Hearing Association has also stated that 1 in 272 Americans are impacted, and nearly 100,000 to 180,000 individuals in the country are diagnosed with aphasia every year.
Moreover, the rising number of people suffering from different neurological ailments, including multiple sclerosis, Parkinson’s disease, and others, resulting in voice and speech disorders, is another factor leading to the rising pool of patients who need speech therapy.
Despite such opportunities, the prohibitive cost of treatment coupled with dearth of speech therapists may impede the U.S. speech therapy market growth. As per the Chairman of Texas Woman's University, Texas requires speech therapists to evaluate and treatment over 200,000 public school students aged between 3 to 21 annually. Therefore, these factors lead to non-availability of such therapies in rural areas of the country.
Top Companies Focus on Forging Partnerships to Deliver Enhanced Solutions
The U.S. speech therapy market represents a fragmented structure, with many companies offering services to the population of patients. BenchMark Physical Therapy Institute, Genesis Rehab Services, and Kindred Healthcare, LLC are some of the leading companies. A diverse array of strategic moves are being adopted by top players in the market to sustain their industry leadership. Some of these strategies include joint ventures, mergers, acquisitions, capacity expansions, and others. Players are investing ample amounts into research and development for the launch of new and innovative capabilities of products. Many companies are also leveraging partnership strategies to offer enhanced services to patients.
List of Key Players Profiled:
- Kindred Healthcare, LLC (U.S.)
- Powerback Rehabilitation to You (U.S.)
- BenchMark Physical Therapy Institute (U.S.)
- Reliant Rehabilitation (U.S.)
- Humanus Corporation (U.S.)
- Smart Speech Therapy (U.S.)
- Therapy Solutions Inc. (U.S.)
- Rehabilitation Associates, Inc. (U.S.)
To get a detailed report summary and research scope of this market, click here:
https://www.fortunebusinessinsights.com/u-s-speech-therapy-market-105574
Key Industry Development
- March 2021 - Kindred Healthcare, LLC announced that it has joined hands with OSF HealthCare. This move is aimed at offering rehabilitation and long-term acute care (LTAC) hospital services in central Illinois.
Further Report Findings
- On the basis of type, the speech disorders segment occupied the largest U.S. speech therapy market share in 2023, which can be ascribed to the increasing incidence of a number of speech disorders, which include apraxia, articulation disorders, aphasia, and others. This factor leads to the growing population of patients in the country and the rising demand for available treatment alternatives. This, coupled with growth in the focus of healthcare facilities on the expansion of their services to serve the surging demand, is contributing to the growth of the segment.
- In terms of age, the pediatrics segment secured the dominating share in 2023, which can be credited to the surging number of children diagnosed with speech disorders, including dysarthria, aphasia, and others that are leading to rising demand for speech therapy among the population in the country. The American Speech-Language-Hearing Association (ASHA) 2024 article reported that nearly one in twelve children in the age group between 3-17 years in the country are diagnosed with a disorder associated with language, voice, speech, or swallowing.
Table of Segmentation
ATTRIBUTE | DETAILS |
Study Period | 2019-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2019-2022 |
Growth Rate | CAGR of 6.9% from 2024-2032 |
Unit | Value (USD Billion) |
Segmentation | By Type
|
By Age
|
- 2023
- 2019-2022
- 63
Clients
- Inquiry Before Buying
-
-